DUSTIN BLUE MANDERS
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine
- Where
- DENISON, TX
- NPI
- 1326241324
- Received
- $171,322 in 216 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 69 | $36,651 |
| 2024 | General payment | 57 | $50,327 |
| 2023 | General payment | 26 | $17,387 |
| 2022 | General payment | 22 | $41,132 |
| 2021 | General payment | 7 | $5,583 |
| 2020 | General payment | 13 | $11,118 |
| 2019 | General payment | 22 | $9,120 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 48 | $144,300 |
| Compensation for serving as faculty or as a speaker for a medical education program | 11 | $12,658 |
| Food and Beverage | 140 | $8,098 |
| Consulting Fee | 5 | $3,084 |
| Travel and Lodging | 8 | $3,076 |
| Education | 4 | $104 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-25 | GlaxoSmithKline, LLC. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-11-20 | Janssen Biotech, Inc. | $24 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-11-03 | GlaxoSmithKline, LLC. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-10-30 | GlaxoSmithKline, LLC. | $122 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-10-30 | Hologic Sales and Service, LLC | $107 | Food and Beverage | In-kind items and services | MYOSURE TISSUE REMOVAL DEVICE Device, Surgical | 2025 | |
| 2025-10-24 | Novartis Pharmaceuticals Corporation | $26 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-10-23 | Eisai Inc. | $1,825 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-10-23 | Eisai Inc. | $730 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-10-23 | Eisai Inc. | $120 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-10-23 | AstraZeneca Pharmaceuticals LP | $24 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-10-17 | PFIZER INC. | $23 | Food and Beverage | In-kind items and services | PADCEV Biological, ONCOLOGY | 2025 | |
| 2025-10-16 | GlaxoSmithKline, LLC. | $103 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-10-16 | Janssen Biotech, Inc. | $20 | Food and Beverage | In-kind items and services | ERLEADA Drug, Oncology | 2025 | |
| 2025-10-10 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-10-10 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-10-08 | GlaxoSmithKline, LLC. | $140 | Travel and Lodging | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-10-08 | Cumberland Pharmaceuticals, Inc. | $17 | Food and Beverage | In-kind items and services | CALDOLOR Drug, ANESTHESIOLOGY PAIN MANAGEMENT | 2025 | |
| 2025-10-02 | GlaxoSmithKline, LLC. | $5,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-25 | GlaxoSmithKline, LLC. | $950 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2025 | |
| 2025-09-25 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-09-18 | GlaxoSmithKline, LLC. | $376 | Travel and Lodging | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-18 | GlaxoSmithKline, LLC. | $207 | Travel and Lodging | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-18 | GlaxoSmithKline, LLC. | $121 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-18 | Merck Sharp & Dohme LLC | $29 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-09-11 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2025 | |
| 2025-09-08 | GlaxoSmithKline, LLC. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-09-04 | AstraZeneca Pharmaceuticals LP | $30 | Food and Beverage | In-kind items and services | ENHERTU Biological, Oncology | 2025 | |
| 2025-08-20 | Eisai Inc. | $1,712 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-08-20 | Eisai Inc. | $685 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-08-20 | Eisai Inc. | $123 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-08-19 | TAIHO ONCOLOGY, INC. | $19 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2025 | |
| 2025-08-14 | GlaxoSmithKline, LLC. | $118 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-08-14 | GlaxoSmithKline, LLC. | $26 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-08-07 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2025 | |
| 2025-08-06 | Ethicon US, LLC | $127 | Food and Beverage | In-kind items and services | STRATAFIX Device, Wound Closure | 2025 | |
| 2025-08-05 | SOBI, INC | $28 | Food and Beverage | In-kind items and services | Vonjo Drug, Hematology/Oncology | 2025 | |
| 2025-07-29 | GlaxoSmithKline, LLC. | $3,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-07-24 | JAZZ PHARMACEUTICALS INC. | $25 | Food and Beverage | In-kind items and services | ZEPZELCA Drug, HEMATOLOGY/ONCOLOGY | 2025 | |
| 2025-07-18 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-07-10 | Eisai Inc. | $33 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-07-03 | GlaxoSmithKline, LLC. | $115 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-06-30 | Eisai Inc. | $342 | Consulting Fee | Cash or cash equivalent | Lenvima Drug, Oncology | 2025 | |
| 2025-06-20 | Merck Sharp & Dohme LLC | $25 | Education | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-06-19 | Bayer Healthcare Pharmaceuticals Inc. | $22 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-06-12 | Deciphera Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | QINLOCK Drug, ONCOLOGY | 2025 | |
| 2025-05-29 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | INLYTA Drug, ONCOLOGY | 2025 | |
| 2025-05-22 | Merck Sharp & Dohme LLC | $27 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2025 | |
| 2025-05-08 | Novartis Pharmaceuticals Corporation | $28 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-05-07 | Myriad Genetic Laboratories, Inc. | $70 | Food and Beverage | In-kind items and services | MYRISK Device, ONCOLOGY | 2025 | |
| 2025-05-01 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2025 | |
| 2025-03-28 | GlaxoSmithKline, LLC. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-03-28 | Novartis Pharmaceuticals Corporation | $27 | Food and Beverage | In-kind items and services | KISQALI Drug, Oncology | 2025 | |
| 2025-03-27 | Daiichi Sankyo Inc. | $25 | Food and Beverage | In-kind items and services | Enhertu Drug, ONCOLOGY | 2025 | |
| 2025-03-25 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | REBLOZYL Biological, HEMATOLOGY | 2025 | |
| 2025-03-20 | EMD Serono, Inc. | $19 | Food and Beverage | Cash or cash equivalent | 2025 | ||
| 2025-03-14 | GENZYME CORPORATION | $17 | Food and Beverage | In-kind items and services | CABLIVI Biological, Hematology | 2025 | |
| 2025-03-13 | GlaxoSmithKline, LLC. | $3,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-03-10 | Novartis Pharmaceuticals Corporation | $16 | Food and Beverage | In-kind items and services | SCEMBLIX Drug, Oncology | 2025 | |
| 2025-03-07 | BeiGene USA, Inc. | $14 | Food and Beverage | In-kind items and services | BRUKINSA Drug, Oncology | 2025 | |
| 2025-03-06 | GlaxoSmithKline, LLC. | $125 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-03-06 | SOBI, INC | $14 | Food and Beverage | In-kind items and services | Doptelet Drug, Hematology/Oncology | 2025 | |
| 2025-02-28 | AstraZeneca Pharmaceuticals LP | $22 | Food and Beverage | In-kind items and services | IMFINZI Biological, Oncology | 2025 | |
| 2025-02-27 | GlaxoSmithKline, LLC. | $120 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2025 | |
| 2025-02-27 | Azurity Pharmaceuticals, Inc. | $24 | Food and Beverage | In-kind items and services | DANZITEN Drug, ONCOLOGY | 2025 | |
| 2025-02-25 | Eisai Inc. | $22 | Food and Beverage | In-kind items and services | Lenvima Drug, Oncology | 2025 | |
| 2025-02-10 | Bayer Healthcare Pharmaceuticals Inc. | $27 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2025 | |
| 2025-01-22 | Myriad Genetic Laboratories, Inc. | $58 | Food and Beverage | In-kind items and services | MYRISK Device, ONCOLOGY | 2025 | |
| 2025-01-22 | Myriad Genetic Laboratories, Inc. | $58 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2025 | |
| 2025-01-16 | Geron Corporation | $23 | Food and Beverage | In-kind items and services | RYTELO Drug, MYELODYSPLASTIC SYNDROME | 2025 | |
| 2024-12-03 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-11-18 | Eisai Inc. | $685 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-11-18 | Stemline Therapeutics Inc. | $23 | Food and Beverage | In-kind items and services | ELZONRIS Drug, Oncology | 2024 | |
| 2024-11-14 | Janssen Biotech, Inc. | $18 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-11-08 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-11-08 | GlaxoSmithKline, LLC. | $32 | Travel and Lodging | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-11-06 | Myriad Genetic Laboratories, Inc. | $60 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2024 | |
| 2024-11-06 | Myriad Genetic Laboratories, Inc. | $59 | Food and Beverage | In-kind items and services | MYRISK Device, ONCOLOGY | 2024 | |
| 2024-10-28 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-10-25 | Stemline Therapeutics Inc. | $24 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2024 | |
| 2024-10-25 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | RYBREVANT Drug, Oncology | 2024 | |
| 2024-10-24 | GlaxoSmithKline, LLC. | $1,584 | Travel and Lodging | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-10-24 | GlaxoSmithKline, LLC. | $124 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-10-17 | GlaxoSmithKline, LLC. | $121 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-10-10 | TAIHO ONCOLOGY, INC. | $23 | Food and Beverage | In-kind items and services | LONSURF Drug, Oncology | 2024 | |
| 2024-10-07 | Ethicon US, LLC | $25 | Food and Beverage | In-kind items and services | STRATAFIX Device, Wound Closure | 2024 | |
| 2024-10-03 | GlaxoSmithKline, LLC. | $121 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-10-01 | Myriad Genetic Laboratories, Inc. | $25 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2024 | |
| 2024-09-26 | AstraZeneca Pharmaceuticals LP | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2024 | |
| 2024-09-20 | GlaxoSmithKline, LLC. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-09-17 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2024 | |
| 2024-09-16 | Ethicon US, LLC | $22 | Food and Beverage | In-kind items and services | VISTASEAL Biological, Biosurgical | 2024 | |
| 2024-09-03 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2024 | |
| 2024-08-23 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2024 | |
| 2024-08-09 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-08-09 | GlaxoSmithKline, LLC. | $400 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2024 | |
| 2024-08-08 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | VERZENIO Drug, Oncology | 2024 | |
| 2024-07-25 | GlaxoSmithKline, LLC. | $119 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2024 | |
| 2024-07-19 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-17 | AstraZeneca Pharmaceuticals LP | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2024 | |
| 2024-07-11 | AstraZeneca Pharmaceuticals LP | $124 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2024 | |
| 2024-07-09 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2024-06-20 | GlaxoSmithKline, LLC. | $65 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-06-20 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | ELAHERE Drug, ONCOLOGY | 2024 | |
| 2024-06-14 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-06-12 | Eisai Inc. | $1,370 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-06-12 | Genmab U.S., Inc. | $139 | Food and Beverage | In-kind items and services | Tivdak Drug, Oncology | 2024 | |
| 2024-05-23 | GlaxoSmithKline, LLC. | $119 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-05-16 | Myriad Genetic Laboratories, Inc. | $41 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2024 | |
| 2024-05-15 | Incyte Corporation | $25 | Food and Beverage | Cash or cash equivalent | JAKAFI Drug, Hematology/Oncology | 2024 | |
| 2024-05-02 | Eisai Inc. | $1,712 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-05-02 | Eisai Inc. | $685 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-05-02 | Eisai Inc. | $86 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-04-24 | Dilon Technologies, Inc. | $149 | Food and Beverage | In-kind items and services | HEMOBLAST BELLOWS Device, HEMOSTATIC AGENT | 2024 | |
| 2024-04-09 | Eisai Inc. | $1,712 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-04-09 | Eisai Inc. | $685 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-04-09 | Eisai Inc. | $108 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-04-01 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2024 | |
| 2024-03-07 | GlaxoSmithKline, LLC. | $120 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2024 | |
| 2024-03-07 | Bayer Healthcare Pharmaceuticals Inc. | $34 | Food and Beverage | In-kind items and services | Nubeqa Drug, Oncology | 2024 | |
| 2024-03-01 | Eisai Inc. | $856 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-02-22 | Eisai Inc. | $856 | Consulting Fee | Cash or cash equivalent | Lenvima Drug, Oncology | 2024 | |
| 2024-02-12 | GlaxoSmithKline, LLC. | $800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | JEMPERLI Biological, ONCOLOGY | 2024 | |
| 2024-02-09 | MENARINI SILICON BIOSYSTEMS, INC. | $20 | Food and Beverage | Cash or cash equivalent | Cellsearch Device, Diagnostics | 2024 | |
| 2024-02-01 | AstraZeneca Pharmaceuticals LP | $13 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-30 | Dilon Technologies, Inc. | $163 | Food and Beverage | In-kind items and services | HEMOBLAST BELLOWS Device, HEMOSTATIC AGENT | 2024 | |
| 2024-01-25 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2024 | |
| 2023-12-14 | Myriad Genetic Laboratories, Inc. | $29 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2023 | |
| 2023-12-14 | Myriad Genetic Laboratories, Inc. | $22 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2023 | |
| 2023-12-14 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-11-30 | SEAGEN INC. | $22 | Food and Beverage | In-kind items and services | TUKYSA Drug, Oncology | 2023 | |
| 2023-11-29 | Myriad Genetic Laboratories, Inc. | $117 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2023 | |
| 2023-11-28 | AstraZeneca Pharmaceuticals LP | $2,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2023 | |
| 2023-11-17 | Eisai Inc. | $1,027 | Consulting Fee | Cash or cash equivalent | Lenvima Drug, Oncology | 2023 | |
| 2023-11-09 | AstraZeneca Pharmaceuticals LP | $842 | Consulting Fee | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2023 | |
| 2023-10-19 | Merck Sharp & Dohme LLC | $15 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-09-28 | Astellas Pharma US Inc | $16 | Food and Beverage | In-kind items and services | Veozah Drug, Biological | 2023 | |
| 2023-09-20 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-09-20 | GlaxoSmithKline, LLC. | $41 | Travel and Lodging | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-08-24 | GlaxoSmithKline, LLC. | $381 | Travel and Lodging | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-08-24 | GlaxoSmithKline, LLC. | $311 | Travel and Lodging | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-08-24 | GlaxoSmithKline, LLC. | $124 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-08-09 | GlaxoSmithKline, LLC. | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-07-26 | GlaxoSmithKline, LLC. | $121 | Food and Beverage | In-kind items and services | JEMPERLI Biological, ONCOLOGY | 2023 | |
| 2023-07-11 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-05-25 | GlaxoSmithKline, LLC. | $117 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2023-05-10 | Stemline Therapeutics Inc. | $20 | Food and Beverage | In-kind items and services | Orserdu Drug, Oncology | 2023 | |
| 2023-04-18 | Merck Sharp & Dohme LLC | $16 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-03-22 | Myriad Genetic Laboratories, Inc. | $37 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2023 | |
| 2023-03-22 | Myriad Genetic Laboratories, Inc. | $37 | Food and Beverage | In-kind items and services | PRECISETUMOR Device, ONCOLOGY | 2023 | |
| 2023-03-22 | Myriad Genetic Laboratories, Inc. | $37 | Food and Beverage | In-kind items and services | MYRISK Device, ONCOLOGY | 2023 | |
| 2023-02-28 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2023 | |
| 2023-01-10 | GlaxoSmithKline, LLC. | $1,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2023 | |
| 2022-12-13 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-12-13 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-11-29 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-11-17 | GlaxoSmithKline, LLC. | $61 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-11-15 | GlaxoSmithKline, LLC. | $96 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-11-10 | GlaxoSmithKline, LLC. | $121 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-11-03 | AstraZeneca Pharmaceuticals LP | $11 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2022 | |
| 2022-10-26 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-10-19 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-09-22 | GlaxoSmithKline, LLC. | $114 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-09-13 | GlaxoSmithKline, LLC. | $123 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-08-09 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-08-02 | Merck Sharp & Dohme LLC | $22 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2022 | |
| 2022-07-21 | GlaxoSmithKline, LLC. | $119 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-06-24 | Merck Sharp & Dohme LLC | $21 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2022 | |
| 2022-06-21 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-05-26 | GlaxoSmithKline, LLC. | $125 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-05-11 | Myriad Genetic Laboratories, Inc. | $108 | Food and Beverage | Cash or cash equivalent | PreciseTumor Device, Tumor DNA Genetic Oncology Analysis | 2022 | |
| 2022-05-10 | GlaxoSmithKline, LLC. | $4,800 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-03-31 | GlaxoSmithKline, LLC. | $96 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-03-08 | GlaxoSmithKline, LLC. | $1,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2022 | |
| 2022-02-22 | Genmab U.S., Inc. | $108 | Food and Beverage | In-kind items and services | TIVDAK Drug, ONCOLOGY | 2022 | |
| 2021-10-19 | Clovis Oncology, Inc. | $168 | Food and Beverage | In-kind items and services | 2021 | ||
| 2021-09-14 | Clovis Oncology, Inc. | $10 | Education | In-kind items and services | Rubraca Drug, Oncology | 2021 | |
| 2021-09-14 | Clovis Oncology, Inc. | $8 | Food and Beverage | In-kind items and services | Rubraca Drug, Oncology | 2021 | |
| 2021-06-29 | GlaxoSmithKline, LLC. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2021 | |
| 2021-06-15 | GlaxoSmithKline, LLC. | $125 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2021 | |
| 2021-04-20 | GlaxoSmithKline, LLC. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2021 | |
| 2021-03-25 | Eisai Inc. | $21 | Food and Beverage | Cash or cash equivalent | Lenvima Drug, Oncology | 2021 | |
| 2020-12-28 | GlaxoSmithKline, LLC. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-12-02 | GlaxoSmithKline, LLC. | $111 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-11-17 | GlaxoSmithKline, LLC. | $4,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-10-30 | Ethicon US, LLC | $14 | Food and Beverage | In-kind items and services | STRATAFIX Device, Wound Closure | 2020 | |
| 2020-10-20 | GlaxoSmithKline, LLC. | $106 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-09-16 | Biom'Up France SAS | $140 | Food and Beverage | In-kind items and services | HemoBlast Bellows Device, Hemostatic Agent | 2020 | |
| 2020-09-10 | Clovis Oncology, Inc. | $3 | Education | In-kind items and services | Rubraca Drug, Oncology | 2020 | |
| 2020-09-01 | AstraZeneca Pharmaceuticals LP | $650 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2020 | |
| 2020-08-25 | Clovis Oncology, Inc. | $64 | Education | In-kind items and services | Rubraca Drug, Oncology | 2020 | |
| 2020-08-20 | AstraZeneca Pharmaceuticals LP | $10 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-06-02 | AstraZeneca Pharmaceuticals LP | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2020 | |
| 2020-05-19 | GlaxoSmithKline, LLC. | $1,000 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ZEJULA Drug, ONCOLOGY | 2020 | |
| 2020-03-03 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2020 | |
| 2019-12-05 | AstraZeneca Pharmaceuticals LP | $19 | Food and Beverage | In-kind items and services | LYNPARZA Drug, Oncology | 2019 | |
| 2019-11-20 | Merck Sharp & Dohme LLC | $14 | Food and Beverage | In-kind items and services | KEYTRUDA Biological, ONCOLOGY | 2019 | |
| 2019-11-13 | AstraZeneca Pharmaceuticals LP | $300 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2019 | |
| 2019-11-10 | AstraZeneca Pharmaceuticals LP | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2019 | |
| 2019-10-31 | TESARO, Inc. | $33 | Food and Beverage | In-kind items and services | ZEJULA Drug, ONCOLOGY | 2019 | |
| 2019-10-28 | AstraZeneca Pharmaceuticals LP | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYNPARZA Drug, Oncology | 2019 |
The latest 200 records of 216.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Denison, TX, county Grayson County, TX, state Texas; placed by its city name.
| Measure | Place (city or town) Denison, TX | County Grayson County, TX | State Texas |
|---|---|---|---|
| Population B01003 | 25,778 | 143,337 | 30,188,424 |
| Population, 2020 census P1 | 24,479 | 135,543 | 29,145,505 |
| Median age B01002 | 40.4 | 39.0 | 35.6 |
| Under 18 B01001 | 25.1% | 24.0% | 25.0% |
| 65 and over B01001 | 20.1% | 18.1% | 13.4% |
| Households B11001 | 10,386 | 55,248 | 10,992,816 |
| Foreign born B05002 | 6.3% | 7.7% | 17.6% |
| Median household income B19013 | $67,365 | $72,182 | $78,476 |
| Median family income B19113 | $82,891 | $88,124 | $94,599 |
| Per capita income B19301 | $34,603 | $38,174 | $40,752 |
| Poverty rate B17001 | 15.0% | 11.2% | 13.8% |
| Unemployment rate B23025 | 4.6% | 3.1% | 5.3% |
| Civilian labor force B23025 | 11,995 | 70,551 | 15,233,563 |
| Mean commute (minutes) B08013 | 19.4 | 25.8 | 26.7 |
| Bachelor's degree or higher B15003 | 18.7% | 23.9% | 33.8% |
| Housing units B25001 | 11,397 | 62,132 | 12,128,515 |
| Owner-occupied B25003 | 58.6% | 66.8% | 62.6% |
| Renters B25003 | 41.4% | 33.2% | 37.4% |
| Median home value B25077 | $180,900 | $248,400 | $283,800 |
| Median gross rent B25064 | $1,309 | $1,310 | $1,403 |
| White, not Hispanic B03002 | 66.5% | 71.1% | 39.1% |
| Black B03002 | 6.8% | 5.1% | 11.9% |
| Hispanic or Latino B03002 | 16.2% | 16.3% | 39.7% |
| Asian B03002 | 1.2% | 1.5% | 5.5% |
| American Indian and Alaska Native B03002 | 0.5% | 0.4% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Denison, TX.
Comments